Patent Cliff
The latest news about Patent Cliff: headlines, AI summaries and the full story from every source.
- Novartis Faces Future Patent Cliffs Despite Optimism for Remibrutinib
- Bank of America Maintains Buy Rating on Merck Following Private Meeting with Chief Medical Officer
- Novo Nordisk CEO Addresses Looming Patent Cliff for Ozempic
- Johnson & Johnson Sees Path to Double-Digit Growth Despite Patent Expirations in 2026
- Pfizer's August Performance Driven by Strong Earnings and Regulatory Advances
- GSK Announces Cost-Savings Plan Amid Q2 Earnings Beat
- Novartis Faces Patent Cliff and Bets on Pipeline to Offset Revenue Losses
- Novartis Reports Better-Than-Expected Q2 Sales Amid Upcoming Patent Challenges
- Novartis Faces Patent Expirations but Sees Growth in New Medicines
- Biopharma M&A Activity Surges as Patent Cliff Drives Deal-Making
- Novartis Q1 Sales Decline Reflects Industry Challenges with Generics and Patent Expirations